The provided notice from Hindalco Industries Limited, dated February 26, 2026, serves as the third update regarding its proposed acquisition of AluChem Companies, Inc. through its step-down subsidiary, Aditya Holdings LLC. The company informed stock exchanges that the statutory review process by the Committee on Foreign Investment in the United States (CFIUS) has been temporarily paused. This delay is a direct result of a partial shutdown of the U.S. federal government, which has tolled the official timelines for regulatory clearances.

During 2025, the acquisition process saw significant procedural milestones, including the filing of both “short-form” and “long-form” declarations with CFIUS to ensure compliance with U.S. national security regulations. However, the current federal shutdown has created an environment where no definitive timeline exists for the resumption of the review. Hindalco has clarified that the transaction remains in a state of “temporary halt” until the U.S. government resumes full operations and the CFIUS framework is reactivated. The company has committed to providing further updates as material developments occur.

Hindalco Industries Limited, the metals flagship of the Aditya Birla Group, is an industry leader in aluminum and copper manufacturing. Throughout 2025, the company focused on expanding its downstream capabilities and specialty alumina portfolio, which prompted the strategic move to acquire AluChem. In recent news from late 2025, Hindalco’s subsidiary, Novelis, continued to make headlines regarding its proposed IPO and massive investment projects in North America. Furthermore, the company has been securing significant orders in the EV and renewable energy sectors, positioning itself as a key supplier for sustainable technology components.

In the last quarterly financial results announced in late 2025, Hindalco reported a robust performance driven by strong volumes in its copper business and improved margins in its Indian aluminum operations. For the quarter ending September 30, 2025, the company saw a consolidated Revenue growth of approximately 7% year-on-year, while Net Profit witnessed a significant surge of over 35% compared to the same period in 2024, aided by lower input costs and better product mix. The company attracts significant interest from institutional giants and “famous” veteran investors; notably, the Life Insurance Corporation of India (LIC) remains one of its largest institutional shareholders, holding a substantial stake that underscores confidence in the company’s long-term growth trajectory.